Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Times Netherlands.
Press releases published on May 8, 2025

Display Week 2025: SunLED to Demo Near-Infrared Technology that Brings the Benefits of Natural Sunlight Indoors
The technology can be integrated into screens to deliver the essential part of sunlight absent in indoor light to users while they work, improving well-being SAN JOSE, CA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- SunLED Life Science, a health- …

AMG Announces Results of its 2025 Annual General Meeting
Amsterdam, 8 May 2025 (Regulated Information) --- AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) is pleased to announce that during its Annual General Meeting held on May 8, 2025, shareholders approved all agenda items presented. During the …

AMG Announces Final 2024 Dividend
Amsterdam, 8 May 2025 (Regulated Information) --- AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) is pleased to announce that during the Annual General Meeting, held on May 8, 2025, AMG's shareholders approved the payment of a dividend of €0 …

Philips shareholders approve all proposals at the AGM 2025
May 8, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re-appointment of Ms Indra Nooyi and Ms …

Transaction in Own Shares
Transaction in Own Shares 8 May, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 8 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading …

Azerion publishes Notice of Annual General Meeting 2025
Azerion publishes Notice of Annual General Meeting 2025 Amsterdam, 8 May 2025 – Azerion Group N.V. has today published the Notice of Annual General Meeting 2025 (AGM), which will be held on 19 June 2025. The notice, agenda and accompanying explanatory …

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
– EMA submission expected in 2H25 by partner Menarini – – PREVAIL Phase 3 CVOT remains on track – -- BROADWAY and TANDEM results presented at EAS with simultaneous publications in the New England Journal of Medicine and The Lancet, respectively -- -- …